Table 2. Clinical results based on HPV status and p16 expression.
Variable | p16+ or HPV+ | p16- or HPV+ | p16+ or HPV- | p16- or HPV- |
Overall survival (in months) (95% CI) | 72.5 (65.2-79.8) | 52.1 (46.3-57.8) | 58.7 (52.6-64.8) | 43.9 (37.8-49.9) |
Disease-free survival (in months) (95% CI) | 65.2 (58.3-72.1) | 42.6 (36.7-48.4) | 51.8 (45.9-57.6) | 35.4 (29.6-41.1) |